Ellen Chiniara

Insider Reports History

Entity
Individual
Location
51 Sawyer Road, Suite 200, Waltham, MA
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ellen Chiniara:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kymera Therapeutics, Inc. Chief Legal Officer Common Stock 54.8K $2.29M $41.75 Jan 6, 2025 Direct
Kymera Therapeutics, Inc. Chief Legal Officer Stock Option (Right to Buy) 131K Mar 1, 2024 Direct
Compass Therapeutics, Inc. Director Stock Option (Right to Buy) 40K Feb 9, 2024 Direct
ALEXION PHARMACEUTICALS, INC. EVP & Chief Legal Officer Common Stock, par value $.0001 per share 0 $177.00 Jul 21, 2021 Direct

Insider Reports Filed by Ellen Chiniara

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KYMR Kymera Therapeutics, Inc. Jan 6, 2025 1 -$131K 4 Jan 6, 2025 Chief Legal Officer
KYMR Kymera Therapeutics, Inc. Mar 1, 2024 2 $0 4 Mar 4, 2024 Chief Legal Officer
CMPX Compass Therapeutics, Inc. Feb 9, 2024 1 $0 4 Feb 14, 2024 Director
KYMR Kymera Therapeutics, Inc. Jan 4, 2024 1 -$74.4K 4 Jan 5, 2024 Chief Legal Officer
CMPX Compass Therapeutics, Inc. Feb 8, 2023 1 $0 4 Feb 9, 2023 Director
KYMR Kymera Therapeutics, Inc. Jan 3, 2023 2 $0 4 Jan 4, 2023 Chief Legal Officer
KYMR Kymera Therapeutics, Inc. Jan 3, 2023 0 $0 3 Jan 4, 2023 Chief Legal Officer
CMPX Compass Therapeutics, Inc. Apr 26, 2022 1 $0 4 Apr 28, 2022 Director
CMPX Compass Therapeutics, Inc. Apr 26, 2022 0 $0 3 Apr 28, 2022 Director
ALXN ALEXION PHARMACEUTICALS, INC. Jul 21, 2021 1 $0 4 Jul 23, 2021 EVP & Chief Legal Officer
ALXN ALEXION PHARMACEUTICALS, INC. Jul 14, 2021 2 $0 4 Jul 16, 2021 EVP & Chief Legal Officer